HFS
RETA

Howard Financial Services’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Howard Financial Services’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-25,325
Closed -$1.42M – 118
2018
Q4 		$1.42M Buy
+25,325
New +$1.55M 1.09% 19

Other funds holding RETA

CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return

Howard Financial Services's RETA Position: Q1 2019 in Review

Howard Financial Services sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q1 2019, closing a stake of 25,325 shares — an estimated $1.42M sold.

Howard Financial Services first reported a position in RETA in Q4 2018 and held it in 1 quarter. The position peaked at $1.42M in Q4 2018. 157 funds tracked by Wall St. Rank hold RETA as of Q1 2019.

  • Howard Financial Services reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q1 2019 after selling out during the quarter.
  • Howard Financial Services sold 25,325 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q1 2019, an estimated $1.42M.
  • Howard Financial Services first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2018 and held it in 1 quarter.
  • Howard Financial Services's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $1.42M in Q4 2018.
  • 157 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q1 2019.

Based on Howard Financial Services's 13F filing for Q1 2019, filed 14 May 2019.